Virtual Pharma

Creation and spread of breakthrough drugs to address unmet medical needs

It takes more than 10 years and 100 billion yen (about $700M) to develop a new drug, and the probability of success is as low as 1 in 20,000 to 30,000. In particular, the creation of new drugs for "rare diseases" and "neglected tropical diseases," which are considered particularly difficult for pharmaceutical companies to commercialize, is often delayed.
And utilizing patients' perspectives in drug research and development is required, but the collection and accumulation of patient data and its application to drug discovery have only just begun.

Fujitsu contributes to create innovative drugs and streamline business processes by transforming the value chain with digital technologies and realize a world in which patients can obtain the drugs they need as quickly as possible.